Quaife, N. M.
Chothani, S.
Schulz, J. F.
Lindberg, E. L.
Vanezis, K.
Adami, E.
O’Fee, K.
Greiner, J.
Litviňuková, M.
van Heesch, S.
Whiffin, N.
Hubner, N.
Schafer, S.
Rackham, O.
Cook, S. A.
Barton, P. J. R. http://orcid.org/0000-0002-1165-7767
Funding for this research was provided by:
Fondation Leducq (16 CVD 03)
NIHR Imperial Biomedical Research Centre
Imperial College Academic Health Science Centre
Rosetrees and Stoneygate Foundation
Deutsches Zentrum für Herz-Kreislaufforschung
Bundesministerium für Bildung und Forschung
Medical Research Council
Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals
Article History
Received: 15 December 2021
Accepted: 9 June 2022
First Online: 27 June 2022
Change Date: 14 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12265-022-10291-4
Declarations
:
: No human or animal studies were carried out by the authors for this article.
: S.A.C and S.S are cofounders and shareholders of Enleofen Bio Pte. Ltd. All other authors declare no competing interests.